Neurochemical sex differences in adult ADHD patients: an MRS study

Table 3 Demographic and psychometric data

	mADHD (n = 48)	fADHD (n = 48)	p value	mADHD (n = 42)	fADHD (n = 42)	p value
	pACC			Cerebellum
Age	33.67 ± 9.911	33.75 ± 9.710	0.967	33.24 ± 10.024	33.17 ± 9.740	0.974
IQ	112.31 ± 15.764	112.23 ± 15.896	0.979	111.79 ± 16.728	112.31 ± 16.418	0.885
WURS-k	39.67 ± 7.467	40.48 ± 9.876	0.650	39.88 ± 7.494	40.60 ± 10.296	0.717
CAARS-inattention	72.98 ± 14.734	74.00 ± 11.924	0.710	73.19 ± 14.737	72.45 ± 12.292	0.804
CAARS-hyperactivity-impulsivity	56.96 ± 13.483	56.13 ± 13.695	0.765	57.93 ± 13.659	54.71 ± 13.834	0.287
CAARS-total symptoms	68.10 ± 13.726	67.75 ± 11.964	0.893	68.86 ± 14.465	65.60 ± 11.698	0.259
CAARS-ADHD Index	64.15 ± 12.821	69.00 ± 11.082	0.050	64.95 ± 13.046	68.00 ± 10.992	0.250
BDI	9.25 ± 6.6270	13.96 ± 8.901	0.004**	9.62 ± 6.748	13.43 ± 897.461	0.031*
Nicotine	7.31 ± 11.532	4.71 ± 10.372	0.248	8.19 ± 12.047	3.69 ± 7.303	0.042*

Abbreviations: IQ intelligence quotient (measured by the MWTB Multiple-Choice Vocabulary Intelligence Test), mADHD adult male ADHD patients, fADHD adult female ADHD patients, WURS-k Wender Utah Rating Scale, CAARS-S:L Conners Adult ADHD Rating Scales-Self Report: Long Version, BDI Beck Depression Inventory, nicotine nicotine consumption in cigarettes per day. For reference see text
*p < 0.05, **p < 0.01

ISSN: 2042-6410